GYNECOLOGIC CANCERS RESEARCH FOUND… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

ANDREW T GOLDSTEIN

Phone

4102790209

Tax Period

2023-01-01 to 2023-12-31

GYNECOLOGIC CANCERS RESEARCH FOUNDATION INC, founded in 2016, is a small nonprofit in the International Affairs sector that reported $256K in total revenue in fiscal year 2023. Net assets of $713K represent 33 months of operating reserves.

Mission

TO PROVIDE RESEARCH FUNDING AND RESOURCES FOR THE TREATMENT OF GYNECOLOGIC CANCERS SUCH AS CERVICAL AND VULVAR CANCERS.

Program Service Accomplishments

Program 1

Expenses: $243,825 Revenue: $256,131

RESEARCH NOVEL TREATMENTS FOR PRECANCEROUS DISEASES SUCH AS LICHEN SCLEROSUS AND PROVIDE SUPPORT TO STUDY THE GENETICS OF THIS DISORDER

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $256,131

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $256,131

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $243,825

Other Expenses $252,920

TOTAL EXPENSES $252,920

Year-over-Year Comparison

	2023	2022	Change
Revenue	$256,131	$252,426	+0.0%
Expenses	$252,920	$72,197	+2.5%
Net Income	$3,211	$180,229	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANDREW GOLDSTEIN	PRESIDENT	10.00	Officer Director	$0	$0	$0
ERIC WILAND	SECRETARY	1.00	Officer Director	$0	$0	$0
KAREN O'KEEFE MD	DIRECTOR	1.00	Director	$0	$0	$0
GAIL GOLDSTEIN	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$256,131	$252,920	$712,849	$3,211
2022	$252,426	$72,197	$709,638	$180,229
2021	$501,060	$5,612	$529,409	$495,448
2020	$81,027	$102,572	$30,389	$-21,545
2018	$377,569	$338,739	$52,066	$38,830

GYNECOLOGIC CANCERS RESEARCH FOUNDATION INC